Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Depakote ER safety in pediatric bipolar mania
NCT00195780Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of divalproex sodium in bipolar I disorder, sponsored by Abbott Laboratories. Primary endpoint: Safety. Started Feb 2005; status: completed.
02
Drugs
divalproex sodium
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT00195780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00195780.